Inpatient 100% mortality review at a NCI Comprehensive Cancer Center Hospital.

Authors

null

Angela Jain

Fox Chase Cancer Center, Havertown, PA

Angela Jain, Delinda Pendleton, Jamie Doyle, Stefan K. Barta, Mark A Hallman, Dwight D. Kloth, Kenneth Patrick, John A. Ridge

Organizations

Fox Chase Cancer Center, Havertown, PA, Fox Chase Cancer Center, Philadelphia, PA, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, Philadelphia, PA, Fox Chase Cancer Center, Philadeplhia, PA

Research Funding

Other

Background: Fox Chase Cancer Center set about to identify opportunities to improve care (OIC) for cancer patients dying in the hospital. The team developed and tested a mortality review decision tree and paradigm that helped to identify OICs. Volunteer members of hospital staff representing most domains of patient care comprised the committee. Monthly meetings defined the review process, developed the form, initiated the program and refined the process as experience accumulated. Methods: Forms incorporated information from Temple University Hospital, Comprehensive Cancer Center Consortium for Quality Improvement(C4QI), and measures to be monitored by CMS. Deaths were considered “anticipated” or “unanticipated,” and with or without OIC. Issues in cases with OIC were recorded for each death. Level 1 review was completed by a research student or a member of the risk management team to organize clinical data. A level 2 review was then performed by a member of the committee and deaths were categorized. Level 3 review was undertaken at monthly meetings and action items determined. Results: From March 2014 to December 2015, 246 cases were reviewed. The elements were chosen for the level 1 & 2 review and collating objective data. Whether the patient was treated with curative intent, procedures were definitive or palliative, if chemotherapy, radiation or surgery were delivered, or if there was a complication within the last 2 weeks of life were recorded. Hospitalization features such as institution of palliative care, appropriate advanced directives, code status on admission and at death, and ICU admission were noted. Issues often arose when deaths were expected and predicted at admission. Increased need for inpatient palliative care teams and hospice support have been recognized. Better communication between patients, families, and oncologists should reduce hospitalization for patients whose death is imminent. Conclusions: Submitting 100% of inpatient deaths to formal mortality review discloses opportunities to improve care and allows focus on problems that occurred even when the patient’s death was expected.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2017 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cost, Value, and Policy in Quality; Practice of Quality

Track

Cost, Value, and Policy in Quality,Practice of Quality

Sub Track

Learning from Projects Done in a Practice

Citation

J Clin Oncol 35, 2017 (suppl 8S; abstract 88)

DOI

10.1200/JCO.2017.35.8_suppl.88

Abstract #

88

Poster Bd #

D5

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Annual Meeting

Racial disparities in utilization of palliative care among inpatients admitted for lung cancer.

First Author: Kavya Bharathidasan

Abstract

2022 ASCO Quality Care Symposium

Palliative care utilization and mortality in patients who received inpatient chemotherapy.

First Author: Justine Anderson

Abstract

2022 ASCO Annual Meeting

Palliative care utilization and mortality in patients who received inpatient chemotherapy.

First Author: Justine Anderson